Celotex Corporation Asbestos Exposure: Products, Workers & Trust Claims
Celotex Corporation manufactured and distributed roofing and building products, some of which contained asbestos. Its subsidiary Carey Canada mined, milled and processed asbestos fiber. The companies’ histories matter when identifying products, reconstructing occupational exposure and investigating an asbestos-related claim.
Celotex and Carey Canada filed for Chapter 11 protection on October 12, 1990. The Celotex Asbestos Settlement Trust, established in 1998, continues to publish claim instructions and payment information. A claim still requires qualifying medical and exposure evidence; employment at a building site alone does not prove exposure to a Celotex product.
Celotex Corporation: Company History & Timeline
The Celotex Asbestos Settlement Trust describes Celotex as a manufacturer and distributor of roofing and building products for residential and commercial construction. Its wholly owned subsidiary Carey Canada previously mined, milled and processed asbestos fiber. The trust states that some products made and sold by Celotex and its predecessors contained asbestos.
October 12, 1990: Celotex and Carey Canada filed for Chapter 11 reorganization. December 6, 1996: A federal bankruptcy court confirmed their modified joint reorganization plan, according to a later federal bankruptcy decision. February 1, 1998: The trust identifies this as its founding date. The trust administers qualifying personal-injury claims under court-approved procedures.
The distinction between Celotex building products and Carey Canada asbestos fiber is important: an investigation should identify which entity’s material was involved, not assume every asbestos-containing building product came from Celotex. For additional manufacturer research, see asbestos companies and asbestos manufacturers.
Celotex Company Facts at a Glance
| Company detail | Documented information |
|---|---|
| Business | Roofing and building products |
| Subsidiary | Carey Canada, asbestos mining, milling and processing |
| Bankruptcy | October 12, 1990 |
| Trust established | February 1, 1998 (not 2006) |
| Official trust | celotextrust.com |
Celotex Asbestos Products & Product Identification
The trust confirms that some Celotex and predecessor products contained asbestos, but its general company history does not establish the composition of every Celotex-branded product. Its records describe roofing and building products broadly; Carey Canada supplied asbestos fiber. Do not treat an ordinary fiberboard, roofing board or insulation product as asbestos-containing solely because it bears the Celotex name.
To identify a product, look for original packaging, manufacturer labels, product literature, architectural specifications, purchasing invoices, material safety information, installation records and photographs. Record the product name, manufacturing period, location and whether the material was cut, removed or disturbed. When available, contemporaneous specifications and competent material analysis are stronger evidence than a visual guess.
The distinction also matters for products made by other manufacturers using Carey Canada fiber. A separate federal bankruptcy decision describes allegations involving Carey fiber in another company’s vinyl asbestos floor tile; that record does not establish that Celotex manufactured those tiles. Explore asbestos exposure in products for additional product-identification context.
Historical Product Categories: Verification Table
| Category named in previous article | Previously stated dates | Publication status |
|---|---|---|
| Insulation board | 1930s–1980s | Product-specific asbestos content and dates not verified; do not present as confirmed. |
| Roofing felts and bitumen | 1940s–1980s | Product-specific asbestos content and dates not verified. |
| Ceiling and wall panels | 1950s–1980s | Product-specific asbestos content and dates not verified. |
| Siding and sheathing | 1960s–1980s | Product-specific asbestos content and dates not verified. |
These are categories and date ranges from the previous article, included transparently for editorial review, not established Celotex asbestos-product facts. Original catalogs, specifications or other primary evidence are needed before publication as verified dates.
How Celotex-Related Asbestos Exposure Could Occur
Potential exposure depends on the specific asbestos-containing product and the work performed. Cutting, sawing, drilling, scraping, tearing out or otherwise disturbing asbestos-containing building materials can release fibers. Workers may also have encountered asbestos during manufacturing, handling or processing of asbestos fiber. These are exposure pathways to investigate, not proof that a particular job involved Celotex material.
Reconstruct the task: Was the product installed intact, mechanically worked, damaged or removed? Was dust generated? Who performed the work and who worked nearby? What ventilation and respiratory protection existed? Dates matter because product formulations and suppliers may have changed.
Contaminated clothing can create a potential secondary-exposure question, but a family member’s exposure must be established separately through evidence of asbestos-contaminated work and transfer into the home.
Workers & Work Settings That May Require Investigation
Roofers, construction tradespeople, demolition workers, maintenance personnel, building renovation crews, warehouse handlers and manufacturing workers may have performed tasks involving roofing or building materials. Carey Canada mining, milling and processing workers had a different potential exposure setting. These occupations are investigative leads; they are not a verified roster of Celotex-exposed workers.
Building plans, roofing specifications, contractor purchase orders, invoices, site photographs, maintenance logs and coworker testimony can establish whether a particular Celotex product was present. The trust’s published criteria require credible exposure evidence; a job title or facility name alone is not enough.
Compare job histories with the site’s high-risk jobs and job-site exposure resources. These broader pages are useful for reconstructing work but do not establish company-specific product identification.
Need help now? Call 800.291.0963
Live chat available 24/7, 365 days a year.
Submit Your Case
Exposure Estimates From the Previous Article: Source Audit
The previous post supplied the following estimates without a traceable methodology. They are preserved here as an editorial audit, not as factual estimates of exposure.
| Employees and on-site workers | Previously claimed count | Status |
|---|---|---|
| Factory employees | 3,000+ | Unverified |
| Warehouse and transport | 1,200+ | Unverified |
| Total direct employee exposure | Approximately 4,200+ | Unverified; not suitable as a published fact |
| Non-employee group | Previously claimed count | Status |
|---|---|---|
| Construction workers | 90,000+ | Unverified |
| Renovation and demolition crews | 50,000+ | Unverified |
| Maintenance and repair technicians | 30,000+ | Unverified |
| Homeowners and secondary exposure | 25,000+ | Unverified |
| Total wider exposure | Approximately 195,000+ | Unverified; not suitable as a published fact |
Military and Government Facilities
Older barracks, mess halls, military housing, VA hospitals, administrative buildings and shelters may warrant asbestos-material investigations. However, this article does not have procurement or building records establishing Celotex product use at any named military or federal facility. Identify the actual product and location before attributing exposure to Celotex.
Asbestos Health Risks & Medical Follow-Up
Inhaled asbestos fibers can cause mesothelioma, asbestos-related lung cancer and nonmalignant asbestos disease. Some illnesses have long latency periods, so a worker may receive a diagnosis decades after the relevant employment. Diagnosis alone, however, cannot identify the manufacturer responsible for an individual’s exposure.
Tell a qualified healthcare professional about relevant jobs, products, dates and symptoms. Medical evaluation and screening decisions should be individualized. Smoking and asbestos can jointly increase lung-cancer risk; neither this page nor a trust filing substitutes for medical advice.
Preserve pathology reports, imaging, diagnosis dates and specialist records if a claim is being considered. The trust’s disease categories and medical criteria are defined by its governing claims procedures, not by a website’s general disease descriptions.
Celotex Bankruptcy & Asbestos Settlement Trust
The official Celotex Asbestos Settlement Trust states that it was founded February 1, 1998, following the bankruptcy of Celotex Corporation and Carey Canada. It processes qualifying asbestos personal-injury claims under court-approved Claims Resolution Procedures. The official website describes two routes: Individualized Review Claims (IRC) and Discounted Cash Payment (DCP) claims.
Published payment percentage: The trust homepage states that its IRC payment percentage is 7% effective June 23, 2023. This is the percentage published on the official homepage when this article was prepared; confirm the latest applicable percentage and the separate DCP terms with the trust before estimating payment. A payment percentage applies to an allowed claim’s applicable liquidated value, not automatically to a headline scheduled or maximum figure.
Official IRC disease-value examples: The trust’s IRC settlement page lists malignant mesothelioma at a $130,000 scheduled value and $325,000 maximum value; Lung Cancer (One) at $39,000 scheduled and $260,000 maximum; and Lung Cancer (Two) at $58,000 scheduled and $260,000 maximum. These are gross valuation figures, not promised payouts. For illustration only, 7% of a $130,000 liquidated value equals $9,100; actual eligibility, review outcome, payment terms and adjustments may differ. The trust lists additional disease categories and criteria in its official procedures.
The official trust FAQ says that a bankruptcy Proof of Claim is not the same as filing a claim with the trust. It identifies March 15, 1996 as the bankruptcy bar date for certain preexisting claims, while people diagnosed after that date may qualify as future-injury claimants. The trust’s claim page says applicable statutes of limitation and its governing procedures still matter. Do not infer that every claim is timely or eligible from these general statements.
For broader context, read how asbestos trust funds work and mesothelioma lawsuit information. A civil lawsuit and a trust claim have different procedures and may interact.
Celotex Settlement Trust Facts
| Trust fact | Information |
|---|---|
| Established | February 1, 1998; the prior 2006 date was incorrect |
| Initial funding | The prior approximately $1.3 billion figure is not confirmed here as an initial-funding amount; do not publish it as verified. |
| Associated entities | Celotex Corporation and Carey Canada |
| IRC payment percentage | 7% effective June 23, 2023, per the trust’s published notice; confirm current terms |
| Website | Official Celotex Asbestos Settlement Trust |
| Eligibility | Claim-specific medical, exposure and filing criteria apply; occupational, residential or take-home exposure alone does not establish eligibility. |
Published Individualized Review Disease Values
| Disease | Scheduled value | Maximum value |
|---|---|---|
| Mesothelioma | $130,000 | $325,000 |
| Lung Cancer (One) | $39,000 | $260,000 |
| Lung Cancer (Two) | $58,000 | $260,000 |
These are published gross valuation figures, not guaranteed payments. For illustration, 7% of an allowed $130,000 liquidated value is $9,100, subject to applicable trust terms and individual review.
Historical Claims: Figures Requiring Original-Report Confirmation
| Measure through 2008 | Figure reported in earlier revision | Editorial status |
|---|---|---|
| Claims filed | 659,299 | Reconfirm against the original Congressional Research Service report before publication |
| Claims paid | 345,839 | Reconfirm against the original report |
| Claim payments | Approximately $772.5 million | Reconfirm against the original report |
Claims filed and paid are not counts of unique people exposed. The figures above are historical, not current trust totals.
Celotex Trust Claim Requirements & Evidence
The trust instructs claimants to submit a complete claim form with supporting medical and exposure documentation. Its FAQ states that claimants may submit through Trust Online or use a paper form; individuals do not have to hire an attorney to file, although the trust cannot advise whether they should obtain one. The official claim page lists the trust mailing address as P.O. Box 1036, Wilmington, DE 19899-1036 and Claimant Relations at 800-708-8925; verify contact information directly before sending sensitive records.
Build an evidence file: identify employers and dates; specify the Celotex product or Carey Canada asbestos fiber; preserve purchase orders, product packaging, installation specifications, work orders and witness details; obtain medical records documenting the diagnosed condition; and review any previous bankruptcy Proof of Claim or trust submissions. Explain how the evidence connects the claimant to the relevant material and exposure circumstances.
Review the official IRC filing guidance, trust FAQs and claims procedures for the applicable medical, exposure and filing standards. A qualified attorney can evaluate the relevant jurisdiction and claim deadlines; compensation is not guaranteed.
Frequently Asked Questions
What did Celotex Corporation manufacture?
The official trust describes Celotex as a manufacturer and distributor of roofing and building products, some of which contained asbestos.
What was Carey Canada’s relationship to Celotex?
Carey Canada was a wholly owned Celotex subsidiary that mined, milled and processed asbestos fiber.
Did every Celotex building product contain asbestos?
No such conclusion follows from the trust’s history. Confirm the exact product, composition and relevant dates.
When did Celotex file for bankruptcy?
Celotex and Carey Canada filed for Chapter 11 protection on October 12, 1990.
Is there an official Celotex asbestos trust?
Yes. The Celotex Asbestos Settlement Trust publishes current claim resources at celotextrust.com and identifies February 1, 1998 as its founding date.
What payment percentage does the trust publish?
Its homepage publishes a 7% IRC payment percentage effective June 23, 2023. Confirm the currently applicable rate and claim-specific terms directly with the trust.
What are IRC and DCP claims?
They are the trust’s Individualized Review and Discounted Cash Payment filing routes, with different valuation and processing features.
Does a diagnosis guarantee a Celotex trust payment?
No. A complete claim must satisfy the applicable medical, exposure, timing and other trust requirements. Compensation is not guaranteed.
Confirmed Primary Sources
- Celotex Asbestos Settlement Trust — About: purpose, founding and claims administration.
- Celotex Trust — Official Homepage: published IRC payment percentage and effective date.
- Celotex Trust — IRC Settlement: scheduled and maximum disease values.
- Celotex Trust — FAQs: eligibility, filing routes and bankruptcy Proof of Claim distinction.
- Celotex Trust — Claims Resolution Procedures: governing criteria and procedures.
- U.S. Bankruptcy Court — Celotex Decision: bankruptcy, plan confirmation and asbestos claims.
Submit Your Case
Call 800.291.0963
Live chat available 24/7, 365 days a year.
Submit Your Case
Working with a Celotex-branded product does not automatically establish asbestos content, exposure, disease causation, claim eligibility, liability or payment. Medical evidence, product identification, exposure history and applicable trust or legal requirements must be evaluated individually. Compensation is not guaranteed.
⚕️ Legal & Medical Information Disclaimer
This page provides general educational information, not medical or legal advice. Consult a qualified healthcare professional about diagnosis or treatment and a qualified attorney about individual legal rights, claim procedures and deadlines.